A new study published in JAMA Network Open cautions that prioritizing blood-based colorectal cancer (CRC) screening tests over stool-based tests…
Browsing: Clinical Updates
AGA’s latest clinical practice update outlines what to do with nonampullary duodenal lesions. These polyps are found in up to…
In 2024, major drug approvals in gastroenterology and hepatology included FDA and EMA authorizations of biosimilars to Stelara and Humira…
Eli Lilly’s Omvoh® (mirikizumab-mkrz) has received FDA approval for treating moderately to severely active Crohn’s disease in adults, marking its…
Fractyl Health announced promising early results from the REVEAL-1 cohort of the REMAIN-1 study, showing weight maintenance one month after…
A Polish observational study revealed that improved adenoma detection rates (ADR) among physicians with a baseline ADR below 26% significantly…
This comprehensive review by the AGA explores best practices in endoscopic enteral access, aiming to guide gastroenterologists in optimizing patient…
In 2024, pivotal advancements in gastrointestinal cancer research have emerged, spotlighting innovative treatments and potential new standards of care. Highlights…
The UK Biobank Pharma Proteomics Project, the largest study of circulating proteins, is set to revolutionize healthcare by enabling earlier…
A systematic review of 26 randomized controlled trials highlights that Eli Lilly’s experimental drug retatrutide achieves the greatest weight loss…